Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Granito

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Liver Cancer|June 26, 2025
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-BevacizumabBernardo Stefanini, Fabio Piscaglia, Fabio Marra, et al.
Cancers|January 21, 2023
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation AnalysisRodolfo Sacco, Daryl Ramai, Raffaella Tortora, et al.
Liver Cancer|August 20, 2025
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational StudyYoon Jun Kim, Philippe Merle, Richard S Finn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2020
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysisÁlvaro Díaz-González, Marco Sanduzzi-Zamparelli, Leonardo G da Fonseca, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 10, 2025
Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated CirrhosisPinelopi Arvaniti, Sergio Rodríguez-Tajes, Marlene Padilla, et al.
JHEP Reports : Innovation in Hepatology|March 1, 2021
Assessing the impact of COVID-19 on liver cancer management (CERO-19)Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Liver Cancer|June 26, 2025
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-BevacizumabBernardo Stefanini, Fabio Piscaglia, Fabio Marra, et al.
Cancers|January 21, 2023
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation AnalysisRodolfo Sacco, Daryl Ramai, Raffaella Tortora, et al.
Liver Cancer|August 20, 2025
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational StudyYoon Jun Kim, Philippe Merle, Richard S Finn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2020
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysisÁlvaro Díaz-González, Marco Sanduzzi-Zamparelli, Leonardo G da Fonseca, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 10, 2025
Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated CirrhosisPinelopi Arvaniti, Sergio Rodríguez-Tajes, Marlene Padilla, et al.
JHEP Reports : Innovation in Hepatology|March 1, 2021
Assessing the impact of COVID-19 on liver cancer management (CERO-19)Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Pageof 14